Earnings Estimate Revisions
Search documents
Nintendo (NTDOY) Upgraded to Strong Buy: What Does It Mean for the Stock?
ZACKS· 2026-01-27 18:01
Investors might want to bet on Nintendo Co. (NTDOY) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a cha ...
All You Need to Know About Workday (WDAY) Rating Upgrade to Buy
ZACKS· 2026-01-27 18:01
Workday (WDAY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The power of a changing ...
Swedbank (SWDBY) Upgraded to Strong Buy: Here's Why
ZACKS· 2026-01-27 18:01
Investors might want to bet on Swedbank AB (SWDBY) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a changi ...
Wintrust (WTFC) Upgraded to Buy: Here's What You Should Know
ZACKS· 2026-01-27 18:01
Core Viewpoint - Wintrust Financial (WTFC) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system focuses on changes in earnings estimates, which are strongly correlated with near-term stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - For Wintrust, the increase in earnings estimates suggests an improvement in the company's underlying business, likely leading to higher stock prices as investors respond positively to this trend [5][8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a proven track record of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [7]. - Wintrust's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating strong potential for market-beating returns in the near term [10]. Earnings Estimate Revisions - For the fiscal year ending December 2026, Wintrust is expected to earn $12.26 per share, with a 2.9% increase in the Zacks Consensus Estimate over the past three months, reflecting analysts' growing confidence in the company's performance [8].
Apollo Commerical Finance (ARI) Upgraded to Buy: Here's What You Should Know
ZACKS· 2026-01-27 18:01
Investors might want to bet on Apollo Commerical Finance (ARI) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by th ...
What Makes Doximity (DOCS) a New Strong Buy Stock
ZACKS· 2026-01-27 18:01
Core Viewpoint - Doximity (DOCS) has received a Zacks Rank 1 (Strong Buy) upgrade, indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in a company's earnings picture, with the consensus of EPS estimates from analysts being a key component [1][2]. - An increase in earnings estimates is strongly correlated with stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4]. Business Improvement Indicators - The upgrade in Doximity's rating suggests an improvement in the company's underlying business, which is expected to lead to higher stock prices as investors respond positively [5][10]. - For the fiscal year ending March 2026, Doximity is projected to earn $1.56 per share, with a 2% increase in the Zacks Consensus Estimate over the past three months [8]. Zacks Rank System Overview - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Only the top 5% of stocks covered by Zacks receive a "Strong Buy" rating, indicating superior earnings estimate revisions and potential for market-beating returns [9][10].
All You Need to Know About Milestone Pharmaceuticals (MIST) Rating Upgrade to Strong Buy
ZACKS· 2026-01-27 18:01
Core Viewpoint - Milestone Pharmaceuticals (MIST) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook driven by rising earnings estimates, which are crucial for stock price movements [1][4]. Earnings Estimates and Revisions - The Zacks Consensus Estimate for Milestone Pharmaceuticals indicates an expected earnings of -$0.71 per share for the fiscal year ending December 2025, showing no year-over-year change [9]. - Over the past three months, analysts have raised their earnings estimates for Milestone Pharmaceuticals by 41.1% [9]. Zacks Rating System - The Zacks rating system is based solely on changes in a company's earnings picture, making it a reliable tool for investors [2][3]. - The system classifies stocks into five groups, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [8]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions [10][11]. Market Implications - The upgrade to Zacks Rank 1 for Milestone Pharmaceuticals suggests an improvement in the company's underlying business, likely leading to increased buying pressure and a rise in stock price [6][11]. - The correlation between earnings estimate revisions and near-term stock movements highlights the importance of tracking these revisions for investment decisions [7].
West Coast Community Bancorp (WCCB) Q4 Earnings Beat Estimates
ZACKS· 2026-01-27 16:10
Core Insights - West Coast Community Bancorp (WCCB) reported quarterly earnings of $1.38 per share, exceeding the Zacks Consensus Estimate of $1.28 per share, and showing an increase from $1.32 per share a year ago, resulting in an earnings surprise of +7.81% [1] - The company posted revenues of $35.78 million for the quarter ended December 2025, which was a miss against the Zacks Consensus Estimate by 0.33%, and an increase from $34.99 million year-over-year [2] - The stock has gained approximately 2.3% since the beginning of the year, outperforming the S&P 500's gain of 1.5% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.27 on revenues of $35.6 million, and for the current fiscal year, it is $5.07 on revenues of $144.6 million [7] - The estimate revisions trend for WCCB was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Banks - Southwest industry, to which WCCB belongs, is currently ranked in the top 26% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]
Wall Street Analysts Predict a 28.05% Upside in Betterware de Mexico SAPI de C (BWMX): Here's What You Should Know
ZACKS· 2026-01-27 15:56
Group 1 - Betterware de Mexico SAPI de C (BWMX) shares have increased by 33.4% over the past four weeks, closing at $18.22, with a mean price target of $23.33 indicating a potential upside of 28.1% [1] - The average price targets range from a low of $20.00 to a high of $30.00, with a standard deviation of $5.77, suggesting a variability in estimates; the lowest estimate indicates a 9.8% increase, while the highest suggests a 64.7% upside [2] - Analysts show strong agreement on BWMX's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for BWMX has increased by 38% due to one estimate moving higher over the last 30 days without any negative revisions [12] - BWMX holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While the consensus price target may not be a reliable indicator of the extent of BWMX's gains, it does provide a directional guide for price movement [14]
Unveiling LPL Financial (LPLA) Q4 Outlook: Wall Street Estimates for Key Metrics
ZACKS· 2026-01-27 15:16
The upcoming report from LPL Financial Holdings Inc. (LPLA) is expected to reveal quarterly earnings of $4.82 per share, indicating an increase of 13.4% compared to the year-ago period. Analysts forecast revenues of $4.81 billion, representing an increase of 36.8% year over year.The consensus EPS estimate for the quarter has been revised 1.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this t ...